Roche, Novartis slam Italian cartel fine

Roche and Novartis have reacted angrily to a decision by the Italian Competition Authority to fine them €182.5m for what it described as "illicit collusion" to exclude Roche's Avastin from the ophthalmology market in favor of Novartis's similar drug Lucentis.